Blood-based biomarkers in mild behavioral impairment: an updated overview

Identifying individuals at-risk for dementia is one of the critical objectives of current research efforts, highlighting the need for simple, cost-effective, and minimally invasive biomarkers. Mild behavioral impairment (MBI), characterized by the emergence of persistent neuropsychiatric manifestati...

Full description

Bibliographic Details
Published in:	Frontiers in Neurology
Main Authors:	Efthalia Angelopoulou, Xenia Androni, Chiara Villa, Alexandros Hatzimanolis, Nikolaos Scarmeas, Sokratis Papageorgiou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	Mild behavioral impairment biomarkers Alzheimer’s disease dementia neuropsychiatric symptoms
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1534193/full

Similar Items

Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology
by: Efthalia Angelopoulou, et al.
Published: (2024-07-01)

Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects
by: Efthalia Angelopoulou, et al.
Published: (2024-01-01)

Review of the prevalence of Mild Behavioral Impairment subdomains in populations from cognitively normal to Mild Cognitive Impairment according to International Society for Advanced Alzheimer's Research and Treatment criteria
by: Virginia Quicchi
Published: (2023-08-01)

Persistence of neuropsychiatric symptoms and dementia prognostication: A comparison of three operational case definitions of mild behavioral impairment
by: Dylan X. Guan, et al.
Published: (2023-10-01)

Mild behavioral impairment in the general population aged 55+ and its association with incident dementia
by: Patricia Gracia‐García, et al.
Published: (2024-10-01)

The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2025-04-01)

The impact of Mild Behavioral Impairment on the individual’s level of psychological, social, and occupational functioning
by: C. Elefante, et al.
Published: (2022-06-01)

Cognitive therapies and their impact on neuropsychiatric symptoms in mild cognitive impairment or dementia: a scoping review
by: Beatriz Lara-Consuegra, et al.
Published: (2025-04-01)

Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms
by: Veronika Matuskova, et al.
Published: (2024-01-01)

Editorial: Neuropsychiatric symptoms and cognitive impairment
by: Ioannis Liampas, et al.
Published: (2025-10-01)

Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers
by: Elizabeth A. Wise, et al.
Published: (2019-12-01)

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits
by: Wietse A. Wiels, et al.
Published: (2021-08-01)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
by: Zahinoor Ismail, et al.
Published: (2023-07-01)

Blood biomarkers in older subjects with mild behavioral impairment: A cross-sectional study from the memory clinic, all india institute of medical sciences, India
by: Abhijith Rajaram Rao, et al.
Published: (2020-01-01)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
by: Eun Jin Yoon, et al.
Published: (2023-01-01)

Validation of the Mild Behavioral Impairment Scale (MBI-S) for brief self-assessment of Mild Behavioral Impairment in people without dementia
by: Paula Hinkl, et al.
Published: (2025-05-01)

Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment
by: Sharon Wang, et al.
Published: (2024-03-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
by: Giulia Arenare, et al.
Published: (2023-08-01)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
by: Natalia Roberto, et al.
Published: (2021-12-01)

Functional connectivity and mild behavioral impairment in dementia‐free elderly
by: Maryam Ghahremani, et al.
Published: (2023-01-01)

Corrigendum: Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort
by: Veronika Matuskova, et al.
Published: (2022-04-01)

Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative
by: Pranitha Y. Premnath, et al.
Published: (2024-01-01)

Advances in research on association between mild behavioral impairment and Alzheimer′s disease
by: LI Yuhang, XIAO Shifu, YUE Ling
Published: (2025-10-01)

Exercise effects on neuropsychiatric symptoms and quality of life in mild cognitive impairment: a systematic review and meta-analysis
by: Liang Chen, et al.
Published: (2024-10-01)

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
by: Byron Creese, et al.
Published: (2023-04-01)

Assessment of prevalence, risk factors, and neuropsychiatric symptoms of mild neurocognitive disorder among elderly in Suez Canal Area
by: Azza Saber Abdelaziz, et al.
Published: (2024-10-01)

Patterns of brain activity during a set-shifting task linked to mild behavioral impairment in Parkinson’s disease
by: Eun Jin Yoon, et al.
Published: (2021-01-01)

Relationship between neuropsychiatric symptoms and social support in older adults with mild behavioral impairment: a moderated mediation model
by: Yanhong Shi, et al.
Published: (2025-09-01)

Geographic Distribution and Future Projections of Mild Cognitive Impairment and Dementia in Greece: Analysis from 1991 to 2050
by: Themis P. Exarchos, et al.
Published: (2025-06-01)

Mild cognitive impairment in adult: A neuropsychological review
by: Ouyang Yanhong, et al.
Published: (2013-01-01)

An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
by: Guo-qing Zheng, et al.
Published: (2016-12-01)

CT-Detected MTA Score Related to Disability and Behavior in Older People with Cognitive Impairment
by: Michele Lauriola, et al.
Published: (2022-06-01)

Cingulate white matter mediates the effects of fecal Ruminococcus on neuropsychiatric symptoms in patients with amyloid-positive amnestic mild cognitive impairment
by: Chun-Che Hung, et al.
Published: (2023-11-01)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
by: Yildiz Degirmenci, et al.
Published: (2023-10-01)

Protocol for a prospective, longitudinal cohort study on the incidence of dementia after the onset of delirium in patients with mild cognitive impairment: MDDCohort (Mild Cognitive Impairment Delirium Dementia)
by: Kyoung Ja Moon, et al.
Published: (2024-11-01)

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders
by: K. Sankhe, et al.
Published: (2025-09-01)

Mild cognitive impairment among older adults in outpatient clinics: Awareness and knowledge needs survey
by: Hong Wang, et al.
Published: (2025-10-01)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
by: Daniella Vellone, et al.
Published: (2022-01-01)

Neuropsychiatric symptoms in Vascular Cognitive Impairment: A systematic review
by: Chan Tiel, et al.

Judgment in Mild Cognitive Impairment and Alzheimer's disease
by: Patrícia Helena Figueirêdo Vale Capucho, et al.